Company Filing History:
Years Active: 2009-2011
Title: Innovations by Bryan Monro Armitage
Introduction
Bryan Monro Armitage is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical devices, particularly in the area of bone cement compositions and cranial flap instruments. With a total of 4 patents to his name, Armitage's work reflects a commitment to enhancing surgical techniques and patient outcomes.
Latest Patents
One of Armitage's latest patents is for bone cement compositions that feature fiber-reinforcement and increased flowability. This invention relates to implantable compositions that include a calcium salt-containing component, which may also contain demineralized bone and a plurality of discrete fibers. The specific aspect ratio of these fibers ranges from about 50:1 to about 1000:1, which significantly enhances mechanical properties such as flexural strength and screw pullout strength.
Another notable patent is the cranial flap clamp instrument. This device includes first and second clamping members along with an extension member. The design allows for secure positioning against the inferior and superior surfaces of a bone flap and skull. The instrument also features a tension limiting assembly, which provides variable designs for limiting the tension exerted during use.
Career Highlights
Throughout his career, Bryan Monro Armitage has worked with prominent companies in the medical field, including Synthes USA, LLC and Synthes GmbH. His experience in these organizations has contributed to his expertise in developing innovative medical devices.
Collaborations
Armitage has collaborated with several professionals in his field, including Sean Hamilton Kerr and Ira C. Ison. These partnerships have likely facilitated the exchange of ideas and advancements in medical technology.
Conclusion
Bryan Monro Armitage's contributions to medical innovation through his patents and collaborations highlight his dedication to improving surgical practices. His work continues to influence the field and enhance patient care.